Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1–40) and (1–42) peptides

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The FASEB Journal

• Publication date

  2002-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1096/fj.02-0829comPMID 12374775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Annexin 5 and apolipoprotein E2 protect against Alzheimer's amyloid-beta-peptide cytotoxicity by competitive inhibition at a common phosphatidylserine interaction site.

  2002cited by this paper
• Cholesterol and Alzheimer's disease: is there a link?

  2002cited by this paper
• Electrophysiologic properties of channels induced by Abeta25-35 in planar lipid bilayers.

  2002cited by this paper
• Cholesterol and Alzheimer's disease.

  2002cited by this paper
• Differential effects of lovastatin treatment on brain cholesterol levels in normal and ApoE-deficient mice

  2001cited by this paper
• Cholesterol and Alzheimer’s disease

  2001cited by this paper
• Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10

  2001cited by this paper
• Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo

  2001influential reference
• Membrane-disordering effects of beta-amyloid peptides.

  2001cited by this paper
• Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology

  2001cited by this paper
• Membrane-disordering effects of β-amyloid peptides

  2001cited by this paper
• Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

  2001influential reference
• Intracellular Calcium Changes in Neuronal Cells Induced by Alzheimer's ß-Amyloid Protein Are Blocked by Estradiol and Cholesterol

  2001cited by this paper
• Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

  2001cited by this paper
• Mechanisms of Amyloid β Protein-Induced Modification in Ion Transport Systems: Implications for Neurodegenerative Diseases

  2001cited by this paper
• Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo.

  2001cited by this paper
• Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region.

  2001cited by this paper
• Alzheimer’s b -Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line*

  2000cited by this paper
• Displacement currents associated with the insertion of Alzheimer disease amyloid beta-peptide into planar bilayer membranes.

  2000cited by this paper
• Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta.

  2000cited by this paper
• Cholesterol Depletion of Enterocytes EFFECT ON THE GOLGI COMPLEX AND APICAL MEMBRANE TRAFFICKING*

  2000cited by this paper
• Mechanism of the

  2000cited by this paper
• Enhancement of 45Ca2+ Influx and Voltage-dependent Ca2+ Channel Activity by β-Amyloid-(1–40) in Rat Cortical Synaptosomes and Cultured Cortical Neurons

  2000cited by this paper
• Properties of cytotoxic peptide-formed ion channels.

  2000cited by this paper
• Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity

  2000cited by this paper
• Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity

  2000cited by this paper
• Cholesterol Depletion of Enterocytes

  2000cited by this paper
• Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

  2000cited by this paper
• Alzheimer's β-Amyloid, Human Islet Amylin, and Prion Protein Fragment Evoke Intracellular Free Calcium Elevations by a Common Mechanism in a Hypothalamic GnRH Neuronal Cell Line*

  2000cited by this paper
• Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.

  2000cited by this paper
• The origins of Alzheimer disease: a is for amyloid.

  2000influential reference
• Amyloid peptide channels: Blockade by zinc and inhibition by Congo red (amyloid channel block)

  2000cited by this paper
• Amyloid beta protein (1-40) forms calcium-permeable, Zn2+-sensitive channel in reconstituted lipid vesicles.

  1999influential reference
• Alzheimer Amyloid Aβ1-42 Channels : Effects of Solvent, pH, and Congo Red.

  1999cited by this paper
• Membrane cholesterol modulates galanin-GalR2 interaction.

  1999cited by this paper
• Alzheimer amyloid aβ1–42 channels: Effects of solvent, pH, and congo red

  1999cited by this paper
• Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

  1998influential reference
• Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol*

  1998cited by this paper
• Cholesterol Depletion of Caveolae Causes Hyperactivation of Extracellular Signal-related Kinase (ERK)*

  1998cited by this paper
• Amyloid β Protein-(1–42) Forms Calcium-permeable, Zn2+-sensitive Channel*

  1998cited by this paper
• Effects of beta-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of A beta 1-42 and A beta 1-43.

  1998cited by this paper
• Effects of β-amyloid peptides on the fluidity of membranes from frontal and parietal lobes of human brain. High potencies of Aβ1-42 and Aβ1-43

  1998cited by this paper
• Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons.

  1997cited by this paper
• Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content.

  1997influential reference
• Lipid Binding to Amyloid β‐Peptide Aggregates: Preferential Binding of Cholesterol as Compared with Phosphatidylcholine and Fatty Acids

  1997cited by this paper
• Cellular Cholesterol Efflux Mediated by Cyclodextrins

  1996cited by this paper
• Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*)

  1996cited by this paper
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• Membrane stiffness and channel function.

  1996cited by this paper
• Zn2+ interaction with Alzheimer amyloid beta protein calcium channels.

  1996cited by this paper
• Cholesterol protects PC12 cells from beta-amyloid induced calcium disordering and cytotoxicity.

  1996cited by this paper
• Intracellular Trafficking of Cholesterol Monitored with a Cyclodextrin*

  1996cited by this paper
• Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein.

  1996influential reference
• Alzheimer's disease amyloid beta peptide 25-35 is localized in the membrane hydrocarbon core: x-ray diffraction analysis.

  1996cited by this paper
• Alzheimer's Disease Amyloid β Peptide 25-35 Is Localized in the Membrane Hydrocarbon Core: X-Ray Diffraction Analysis

  1996cited by this paper
• Cellular Cholesterol Efflux Mediated by Cyclodextrins (*)

  1995cited by this paper
• beta-Amyloid peptide decreases membrane fluidity.

  1995cited by this paper
• Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor.

  1995cited by this paper
• β-amyloid peptide decreases membrane fluidity

  1995cited by this paper
• beta-Amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease.

  1994cited by this paper
• beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.

  1994cited by this paper
• Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide.

  1994cited by this paper
• Amyloid β protein‐induced irreversible current in rat cortical neurones

  1994cited by this paper
• Amyloid beta protein-induced irreversible current in rat cortical neurones.

  1994cited by this paper
• β-amyloid increases choline conductance of PC12 cells: possible mechanism of toxicity in Alzheimer's disease

  1994cited by this paper
• β-amyloid Ca2+-channel hypothesis for neuronal death in Alzheimer Disease

  1994cited by this paper
• Theoretical models of the ion channel structure of amyloid beta-protein.

  1994cited by this paper
• β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease

  1993cited by this paper
• Amyloid beta peptides act directly on single neurons.

  1993cited by this paper
• Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes.

  1993cited by this paper
• Amyloid β peptides act directly on single neurons

  1993cited by this paper
• beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

  1993cited by this paper
• Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum.

  1993cited by this paper
• Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

  1992cited by this paper
• The discovery and development of HMG-CoA reductase inhibitors.

  1992influential reference
• beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity

  1992cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990influential reference
• β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage

  1990cited by this paper
• Zn 2 + interaction with Alzheimer amyloid ( 3 protein calcium channels

  year unknowncited by this paper

• Dynamic instability in nanoscale lipid domains revealed by contact mode high speed AFM: effect of amyloid-β and cholesterol content

  2025cites this paper
• The Influence of POPC as a Coaggregate in Amyloid‑β Oligomer Formation

  2025cites this paper
• Organic Chimeras Based on Selenosugars, Steroids, and Fullerenes as Potential Inhibitors of the β-amyloid Peptide Aggregation.

  2024cites this paper
• The Effect of Calcium Ions on hIAPP Channel Activity: Possible Implications in T2DM

  2023cites this paper
• sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides

  2023cites this paper
• Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease

  2022cites this paper
• Amyloid β Dodecamer Disrupts the Neuronal Membrane More Strongly than the Mature Fibril: Understanding the Role of Oligomers in Neurotoxicity

  2022cites this paper
• Adaptive Membrane Fluidity Modulation: A Feedback Regulated Homeostatic System Hiding in Plain Sight

  2021cites this paper
• Adaptive Membrane Fluidity Modulation: A Feedback Regulated Homeostatic System and Target for Pharmacological Intervention

  2021cites this paper
• Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau

  2021cites this paper
• Alpha-Synuclein and Lipids: The Elephant in the Room?

  2021cites this paper
• Investigation of serum Seladin-1 / DHCR24 levels in breast cancer patients

  2020cites this paper
• Multiscale Analysis of the Amyloid Degradation Toxicity Hypothesis of Alzheimer’s Disease

  2020cites this paper
• Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway

  2020cites this paper
• Melatonin alters fluid phase co-existence in POPC/DPPC/cholesterol membranes

  2020cites this paper
• Influence of human amylin on the membrane stability of rat primary hippocampal neurons

  2020cites this paper
• Bioactive Lipids and the Gut-Brain Axis: Diet as a Modulator of Bioactivity and Diversity of Lipids in the Brain.

  2019cites this paper
• Characterisation of Cholesterolcontaining Microparticles in Autoimmunity

  2019cites this paper
• Amyloid Oligomers, Protofibrils and Fibrils.

  2019cites this paper
• Transient binding, oligomerization and activity of the antimicrobial protein granulysin on eukaryotic and prokaryotic membranes

  2019cites this paper
• Modelling mitochondrial dysfunction in Alzheimer’s disease using human induced pluripotent stem cells

  2019cites this paper
• Interactions of Aromatase and Seladin-1: A Neurosteroidogenic and Gender Perspective

  2019cites this paper
• The mechanism of phosphatidylcholine‐induced interference of PAP (248‐286) aggregation

  2019cites this paper
• A Novel Contrast Agent Based on Magnetic Nanoparticles for Cholesterol Detection as Alzheimer’s Disease Biomarker

  2019cites this paper
• Cell Biology International

  2019cites this paper
• Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy.

  2018cites this paper
• Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause

  2018cites this paper
• Amyloid Beta Peptide Is Released during Thrombosis in the Skin

  2018cites this paper
• Amyloid and membrane complexity: The toxic interplay revealed by AFM.

  2018cites this paper
• Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I

  2018cites this paper
• Cholesterol Regulation of Pulmonary Endothelial Calcium Homeostasis.

  2018cites this paper
• Epigenetic characterisation of ANK1, a novel gene implicated in Alzheimer’s disease (AD)

  2018cites this paper
• Investigation of the interaction of amyloid β peptide (11-42) oligomers with a 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membrane using molecular dynamics simulation.

  2018cites this paper
• Evidence from ITIR-FCS Diffusion Studies that the Amyloid-Beta (Aβ) Peptide Does Not Perturb Plasma Membrane Fluidity in Neuronal Cells.

  2018cites this paper
• Molecular Simulations of Amyloid Structures, Toxicity, and Inhibition

  2017cites this paper
• Amyloid β Ion Channels in a Membrane Comprising Brain Total Lipid Extracts.

  2017cites this paper
• Title Amyloid beta Ion Channels in a Membrane Comprising Brain Total Lipid Extracts Permalink

  2017cites this paper
• Involvement of Astrocytes in Alzheimer’s Disease from a Neuroinflammatory and Oxidative Stress Perspective

  2017cites this paper
• Cholesterol Changes the Mechanisms of Aβ Peptide Binding to the DMPC Bilayer

  2017cites this paper
• The Level of NMDA Receptor in the Membrane Modulates Amyloid-β Association and Perforation

  2017cites this paper
• Detection of misfolded protein aggregates from a clinical perspective

  2016cites this paper
• In vitro hepatotoxicity and herb-drug interactions of selected African plant extracts

  2016cites this paper
• Elucidating novel dysfunctional pathways in Alzheimer's disease by integrating loci identified in genetic and epigenetic studies

  2016cites this paper
• Amyloid beta oligomers induce neuronal elasticity changes in age-dependent manner: a force spectroscopy study on living hippocampal neurons

  2016cites this paper
• The Level of NMDA Receptor in the Membrane Modulates Amyloid-β Association and Perforation

  2016cites this paper
• Mecanismo de acción de la molécula ácido 2-hidroxi-docosahexaenoico en el tratamiento de la Enfermedad del Alzheimer: Identificación de potenciales receptores en el cerebro

  2016cites this paper
• Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes*

  2016cites this paper
• Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F35

  2016cites this paper
• Membrane Cholesterol Modulates Superwarfarin Toxicity.

  2016cites this paper
• Amyloid-β Activates Microglia and Regulates Protein Expression in a Manner Similar to Prions

  2015cites this paper
• Characterization of the interactions between β‐amyloid peptide and the membranes of human SK‐N‐SH cells

  2015cites this paper
• Electrophysiology of Unconventional Channels and Pores

  2015cites this paper
• The influence of cholesterol on membrane protein structure, function, and dynamics studied by molecular dynamics simulations.

  2015cites this paper
• Neuroprotective effects of estrogens: the role of cholesterol

  2015cites this paper
• Antioxidant bioactive compounds in tomato fruits at different ripening stages and their effects on normal and cancer cells

  2015cites this paper
• Chapter 11 – Alzheimer’s Disease

  2015cites this paper
• Chaperonotherapy for Alzheimer’s Disease: Focusing on HSP60

  2015cites this paper
• Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease

  2015cites this paper
• Micellar extraction possesses a new advantage for the analysis of Alzheimer’s disease brain proteome

  2015cites this paper
• Fluoride-Induced Hypercholesterolemia Could Be Protective In Fluorosis : High Cholesterol Attenuates Fluoride Toxicity In In Vitro and In Vivo Assays

  2015cites this paper
• Alzheimer's Aβ interacts with cellular prion protein inducing neuronal membrane damage and synaptotoxicity.

  2015cites this paper
• ApoA-I/HDL Generation and Intracellular Cholesterol Transport through Cytosolic Lipid-Protein Particles in Astrocytes

  2014cites this paper
• Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)

  2014cites this paper
• Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology

  2014cites this paper
• The Role of Cholesterol Metabolism in Alzheimer’s Disease

  2014cites this paper
• Plasma Membrane Injury Depends on Bilayer Lipid Composition in Alzheimer's Disease

  2014cites this paper
• Cholesterol drives aβ(1-42) interaction with lipid rafts in model membranes.

  2014cites this paper
• Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides.

  2014cites this paper
• Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer’s disease

  2014cites this paper
• Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.

  2014cites this paper
• Amyloid-β aggregation with gold nanoparticles on brain lipid bilayer.

  2014cites this paper
• Metabolic features of the cell danger response.

  2014cites this paper
• Localization of amyloid beta (Aβ1‐42) protofibrils in membrane lateral compartments: Effect of cholesterol and 7‐Ketocholesterol

  2014cites this paper
• Amyloid Aggregation: Role of Biological Membranes and the Aggregate-Membrane System.

  2014cites this paper
• Mechanism of cholesterol‐assisted oligomeric channel formation by a short Alzheimer β‐amyloid peptide

  2014cites this paper
• In Vitro Characterization of Unmodified and Pyroglutamylated Alzheimer's Amyloid beta peptide

  2014cites this paper
• Cholesterol and metal ions in Alzheimer's disease.

  2014cites this paper
• The oligomer species: mechanistics and biochemistry

  2013cites this paper
• PrP106-126 and Aβ1-42 Peptides Induce BV-2 Microglia Chemotaxis and Proliferation

  2013cites this paper
• The effect of oxysterols on the interaction of Alzheimer's amyloid beta with model membranes.

  2013cites this paper
• The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity.

  2013cites this paper
• Membrane proteomics by high performance liquid chromatography–tandem mass spectrometry: Analytical approaches and challenges

  2013cites this paper
• The Impact of Cholesterol, DHA, and Sphingolipids on Alzheimer's Disease

  2013cites this paper
• Small Amphipathic Molecules Modulate Secondary Structure and Amyloid Fibril-forming Kinetics of Alzheimer Disease Peptide Aβ1–42

  2012cites this paper
• Comparison of extraction methods for the comprehensive analysis of mouse brain proteome using shotgun-based mass spectrometry.

  2012cites this paper
• Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer’s Disease Pathogenesis

  2012cites this paper
• Membrane pores in the pathogenesis of neurodegenerative disease.

  2012cites this paper
• Relationship Between the Neuroprotective Effects of Insulin‐Like Growth Factor‐1 and 17β‐Oestradiol in Human Neuroblasts

  2012cites this paper
• Hormonal modulation of cholesterol: experimental evidence and possible translational impact

  2012cites this paper
• Cholesterol promotes the interaction of Alzheimer β-amyloid monomer with lipid bilayer.

  2012cites this paper
• Fibrillar α-synuclein and huntingtin exon 1 assemblies are toxic to the cells.

  2012cites this paper
• Structural features and cytotoxicity of amyloid oligomers: implications in Alzheimer's disease and other diseases with amyloid deposits.

  2012cites this paper
• Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer's disease.

  2012cites this paper
• p75NTR is mainly responsible for Aβ toxicity but not for its internalization: a primary study

  2012cites this paper
• Clustering and Internalization of Toxic Amylin Oligomers in Pancreatic Cells Require Plasma Membrane Cholesterol*

  2011cites this paper
• Fluorescent Analysis of the Cell-Selective Alzheimer's Disease Aβ Peptide Surface Membrane Binding: Influence of Membrane Components

  2011cites this paper
• Differenzielle Sortierung von VGlut1 und 2 und mögliche funktionelle Aspekte

  2011cites this paper
• Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein

  2011cites this paper
• Aβ Internalization by Neurons and Glia

  2011cites this paper
• Membrane cholesterol enrichment prevents Aβ-induced oxidative stress in Alzheimer's fibroblasts.

  2011cites this paper